CRISPR licence extension keeps Horizon Discovery at “forefront of gene editing” – Proactive Investors UK
Proactive Investors UK |
CRISPR licence extension keeps Horizon Discovery at “forefront of gene editing”
Proactive Investors UK “Through the extension of our CRISPR license with ERS Genomics, we now have a deeper toolbox of gene editing options, which includes our exclusive rAAV technology, to apply to the generation of GMP biomanufacturing cell lines.” On a separate note, the … The UK Steps Up its Game in Automated CRISPR Gene Editing Horizon broadens gene editing capabilities: CRISPR license extension & grant-funded research |
